Clincosm LogoSign in Get a demo

Type 2 Diabetes

Showing NaN - NaN of 55
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes, Obesity, Overweight Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • +3 more
  • Los Angeles, California
  • +91 more
Jul 10, 2023

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Antihyperglycemic medication)

Not yet recruiting
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +96 more
Aug 8, 2022

Type 2 Diabetes Trial in Atlanta (Educational Video about SCB, Survey on child feeding and related knowledge and practices,

Recruiting
  • Type 2 Diabetes
  • Educational Video about SCB
  • +2 more
  • Atlanta, Georgia
    Children's Healthcare of Atlanta - Hughes Spalding Hospital
May 31, 2022

Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • +2 more
  • Birmingham, Alabama
  • +74 more
Apr 18, 2022

Type 2 Diabetes Trial in Atlanta, New York, Spokane (Degludec, Glargine, Aspart)

Completed
Has Results
  • Type 2 Diabetes
  • Atlanta, Georgia
  • +3 more
Mar 25, 2022

End-Stage Renal Disease, Type 2 Diabetes Trial in Atlanta (Dexcom real-time G6 Continuous Glucose Monitoring System (CGM), POC

Recruiting
  • End-Stage Renal Disease
  • Type 2 Diabetes
  • Dexcom real-time G6 Continuous Glucose Monitoring System (CGM)
  • POC BG
  • Atlanta, Georgia
  • +1 more
Feb 18, 2022

Type 2 Diabetes Trial in Puerto Rico, United States (LY900014, Insulin Glargine)

Completed
  • Type 2 Diabetes
  • Concord, California
  • +31 more
Feb 24, 2022

Type 2 Diabetes Trial in United States (BT-001, Physician-guided Standard of Care for type 2 diabetes)

Active, not recruiting
  • Type 2 Diabetes
  • BT-001
  • Physician-guided Standard of Care for type 2 diabetes
  • San Francisco, California
  • +5 more
Jan 13, 2022

Type 2 Diabetes Trial in Miami, Atlanta, New York (Liraglutide + OADs, Glargine + OADs)

Completed
Has Results
  • Type 2 Diabetes
  • Liraglutide + OADs
  • Glargine + OADs
  • Miami, Florida
  • +4 more
Oct 5, 2021

Type 2 Diabetes Trial in Atlanta (Plant-based diet with no oxysterols, Standard ADA Diet (SADA))

Recruiting
  • Type 2 Diabetes
  • Plant-based diet with no oxysterols
  • Standard ADA Diet (SADA)
  • Atlanta, Georgia
    Morehouse School of Medicine
Oct 8, 2021

Type 2 Diabetes, PreDiabetes Trial in Atlanta (NDPP + Basketball (BB), NDPP Standard of Care SOC)

Enrolling by invitation
  • Type 2 Diabetes
  • PreDiabetes
  • NDPP + Basketball (BB)
  • NDPP Standard of Care SOC
  • Atlanta, Georgia
    Kaiser Permanente Georgia, Center for Research and Evaluation
Sep 24, 2021

TODAY Genetics Study

Completed
  • Type 2 Diabetes
    • Little Rock, Arkansas
    • +24 more
    Jul 28, 2021

    Type 1 Diabetes, Type 2 Diabetes Trial in Aurora, Atlanta (Guardian Sensor (3))

    Completed
    Has Results
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Guardian Sensor (3)
    • Aurora, Colorado
    • +1 more
    Aug 28, 2020

    Type 2 Diabetes Trial in Atlanta, Minneapolis, Cleveland (Glargine U300, Glargine U100, Glulisine Insulin)

    Completed
    Has Results
    • Type 2 Diabetes
    • Glargine U300
    • +2 more
    • Atlanta, Georgia
    • +3 more
    Apr 23, 2020

    Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

    Completed
    Has Results
    • Cardiovascular Disease
    • +4 more
    • Lorcaserin hydrochloride
    • Placebo
    • Alexander City, Alabama
    • +498 more
    Jun 27, 2019

    Type 2 Diabetes Trial in Atlanta (Exenatide, Glargine, Rapid-acting insulin analogs)

    Completed
    Has Results
    • Type 2 Diabetes
    • Atlanta, Georgia
    • +1 more
    May 28, 2019

    Type 2 Diabetes Trial in United States (Salsalate, Placebo)

    Completed
    Has Results
    • Type 2 Diabetes
    • New Haven, Connecticut
    • +15 more
    Mar 25, 2019

    Type 2 Diabetes Trial in United States (ITCA 650 (exenatide in DUROS))

    Terminated
    • Type 2 Diabetes
    • ITCA 650 (exenatide in DUROS)
    • Birmingham, Alabama
    • +50 more
    Mar 4, 2019

    Type 2 Diabetes Trial in United States (Linagliptin, Basal Bolus, Linagliptin + 50% Glargine dose on discharge)

    Completed
    Has Results
    • Type 2 Diabetes
    • Denver, Colorado
    • +4 more
    Feb 18, 2019

    Type 2 Diabetes, Hyperglycemia Trial in United States (sliding scale regular insulin (SSRI), Basal Bolus, Basal Plus)

    Completed
    Has Results
    • Type 2 Diabetes
    • Hyperglycemia
    • sliding scale regular insulin (SSRI)
    • +2 more
    • Atlanta, Georgia
    • +4 more
    Sep 14, 2018

    Type 2 Diabetes Trial in United States (Insulin Pump therapy)

    Completed
    • Type 2 Diabetes
    • Insulin Pump therapy
    • La Jolla, California
    • +5 more
    Sep 20, 2017

    Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide (HOE901/AVE0010), Insulin glargine (HOE901), Metformin

    Completed
    Has Results
    • Type 2 Diabetes
    • Insulin glargine/lixisenatide (HOE901/AVE0010)
    • +2 more
    • Birmingham, Alabama
    • +235 more
    Mar 31, 2017

    Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide Fixed Ratio Combination, Insulin glargine (HOE901),

    Completed
    Has Results
    • Type 2 Diabetes
    • Insulin glargine/lixisenatide Fixed Ratio Combination
    • +3 more
    • Phoenix, Arizona
    • +272 more
    Mar 31, 2017

    Type 1 Diabetes, Type 2 Diabetes Trial in Atlanta (Regular Insulin, Humalog)

    Withdrawn
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Atlanta, Georgia
      Emory Healthcare Ambulatory Surgical Center
    Mar 13, 2017

    Type 2 Diabetes, Obesity Trial in United States (EndoBarrier, Sham Procedure)

    Terminated
    Has Results
    • Type 2 Diabetes
    • Obesity
    • EndoBarrier
    • Sham Procedure
    • Birmingham, Alabama
    • +24 more
    Dec 2, 2016